UNITED STATES OF AMERICA
Before the
SECURITIES AND EXCHANGE COMMISSION
SECURITIES EXCHANGE ACT OF 1934
Release No. 90048 / September 29, 2020
The Securities and Exchange Commission announced the temporary suspension, pursuant to
Section 12(k) of the Securities Exchange Act of 1934, of trading in the securities of Vitro
Diagnostics, Inc. (“VODG”) (CIK No. 0000793171), of Golden, CO, commencing at 9:30 a.m.
EDT on September 30, 2020, and terminating at 11:59 p.m. EDT on October 13, 2020.
The Commission temporarily suspended trading in the securities of VODG due to a lack of
current and accurate information about the company because it has not filed certain periodic
reports with the Commission.
The Commission cautions broker-dealers, shareholders, and prospective purchasers that they
should carefully consider the foregoing information along with all other currently available
information and any information subsequently issued by the company.
Further, brokers and dealers should be alert to the fact that, pursuant to Rule 15c2-11 under the
Exchange Act, at the termination of the trading suspension, no quotation may be entered unless
and until they have strictly complied with all of the provisions of the rule. If any broker or dealer
has any questions as to whether or not it has complied with the rule, it should not enter any
quotation but immediately contact the staff in the Division of Trading and Markets, Office of
Interpretation and Guidance, at (202) 551-5777. If any broker or dealer is uncertain as to what is
required by Rule 15c2-11, it should refrain from entering quotations relating to VODG’s
securities until such time as it has familiarized itself with the rule and is certain that all of its
provisions have been met. If any broker or dealer enters any quotation which is in violation of
the rule, the Commission will consider the need for prompt enforcement action.
If any broker-dealer or other person has any information that may relate to this matter, they
should immediately contact Sheldon L. Pollock, Assistant Regional Director, at 212-336-1100.
The Commission appreciates the assistance of the Financial Industry Regulatory Authority.
